Cove Street Capital analyzes the AI market mania and shifting software valuations. Read the full analysis for more details.

After an eventful weekend, it seems pretty clear that March is going to be very different from the month of February, but ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services ...

The story for February was the surging Australian dollar running into incredible profit growth forecasts. Profit forecasts got stronger throughout the month, helping share prices higher, but for ...

Learn the essential criteria for medical device commercialization in 2026, from AI to global compliance and market trends.

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial intelligence (AI). He is applying this to transferring as much of the load as ...

HitPaw, a leading provider of AI-powered creative tools, announced the release of HitPaw FotorPea V5.3.0, which focuses on making AI image editing smarter and more efficient. This update introduces ...

Weis Markets Inc (WMK) is expected to report for 4Q. Yext Inc (YEXT) is expected to report $0.06 for 4Q. Zenas BioPharma Inc (ZBIO) is expected to report for 4Q. enCore Energy Corp (EU.V) is expected ...

The closure of the Strait of Hormuz (SoH) following escalating US-Israel-Iran tensions has delivered a supply shock of structural proportions to India's energy sector ...

The Decentralized Clinical Trials market, valued at USD 8.87 billion in 2024, is expected to register revenue CAGR of 10.2%.Request free copy of this report: 05, 2026- Growing demand for ...

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) ...

Q4 2025 Earnings Call March 5, 2026 4:30 PM ESTCompany ParticipantsStephen Silvestro - President & CEOEdward Stelmakh ...